This Solicitation opportunity from Department Of Defense was posted on August 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
MAROPITANT CITRATE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Maropitant Citrate, a veterinary pharmaceutical product, is being procured in 160mg tablet form, packaged in blister packs containing four tablets per unit, with the unit of issue being a package (PG) of four tablets. The product must be stored at controlled room temperature between 20–25°C (68–77°F), with allowable excursions between 15–30°C (59–86°F), and is subject to a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging and marking must adhere to commercial standards specified in the procurement document, with each unit sealed in a protective container to prevent damage, and all shipments packed in suitable commercial exterior containers to ensure safe delivery at the lowest carriage rate. Medical acquisitions require compliance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and the product must be labeled in accordance with this standard, as defined by DLA Troop Support. The item is regulated by the FDA, and purchasers must submit a referral to the product specialist for confirmation prior to award, including bidder and manufacturer details. The product is supplied under a fixed-price contract with delivery required 88 days after order placement, FOB destination, at the designated U.S. military medical logistics facility in Kaiserslautern, Germany, with a secondary parcel post address in APO AE 09227-0000. Quantity is fixed at one package, with zero variance allowed, and inspection and acceptance occur at the destination point by the government. The solicitation incorporates multiple FAR and DFARS clauses related to small business representation, employment equity, trafficking in persons, cybersecurity, hazardous materials, and contracting procedures, including deviations applying to all referenced clauses. Compliance with DLA Packaging Requirements for Procurement (RP001) and the DLA Master List of Technical and Quality Requirements is mandatory. Offerors must hold a UEI and CAGE code, and all deliveries must be accompanied by proper documentation, with invoicing to be processed through Wide Area WorkFlow (WAWF). No pricing details are provided in the solicitation, and evaluation factors for award are not explicitly stated. The contract includes strict controls on hazardous materials, requiring Safety Data Sheets and compliance with OSHA’s Hazard Communication Standard, and prohibits the use of hexavalent chromium. Cybersecurity requirements are enforced under NIST SP 800-171 and safeguard
General Info
Place of Performance
ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
MAROPITANT CITRATE, VETERINARY
.
MAROPITANT 160MG TABLET; BLISTER PACK CONTAINING 4 TABLETS
PER PERFORATED SHEET.
.
UNIT OF ISSUE: PACKAGE (PG) OF 4 TABLETS
.
STORED AT CONTROLLED ROOM TEMPERATURE 20-25 C (68-77 F) WITH EXCURSIONS
BETWEEN 15-30 C (59-86 F).
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . .. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
ZOETIS INC. 0M1P3 P/N NDC54771-8180-02 PATTERSON VETERINARY SUPPLY, INC. 3G5T7 P/N 07-894-9960 PATTERSON VETERINARY SUPPLY, INC. 3G5T7 P/N 07-895-2189 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 083539 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 084232 COVETRUS NORTH AMERICA, LLC 4PG41 P/N NDC11695-7032-01 COVETRUS NORTH AMERICA, LLC 4PG41 P/N NDC17033-0009-04
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments%
SPE2DP-26-T-4497
SECTION B
PR: 7017761633 PRLI: 0001 CONT’D
2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017761633 0001 PG 1.000
NSN/MATERIAL:6509016524884
DELIVERY (IN DAYS):0088
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:A
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
WK4FV1
W0CC USA MED MAT CTR EUR
CMR 469
ATTN CL VIII MED REQ PROCES ACT
APO AE 09227-0000
SPE2DP-26-T-4497
SECTION B
PR: 7017761633 PRLI: 0001 CONT’D
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
WK4FV1
W0CC USA MED MAT CTR EUR
USAMMC E DISTR AND TRANS DIVISION
LUDWIGSHAFENERSTRASSE 31 BLDG 2369
KAISERSLAUTERN 67657
DE
Need Ship Date:00/00/0000 Original Required Delivery Date:08/05/2026
SPE2DP-26-T-4497 NSN/Part Number: 6509-01-652-4884 Quantity: 1 PG Purchase Request: 7017761633QTY: 1 Delivery: 88 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
